, 68:837 | Cite as

Stability Indicating LC Assay Method for the Determination of Famciclovir in Bulk Drug and Pharmaceutical Dosage Forms

  • Ch. B. V. Narasimha Raju
  • Gunanidhi Panda
  • G. Nageswara Rao
Full Short Communication


A simple isocratic stability indicating LC method was developed and validated for the determination of famciclovir in bulk drug and pharmaceutical dosage form. A mixture of 0.05 M potassium dihydrogen orthophosphate buffer and acetonitrile (80:20 v/v) was used as mobile phase at a flow rate of 1.0 mL min−1. Hypersil BDS C18 (250 mm × 4.6 mm × 5 μm) column was used and the eluents were monitored at 220 nm. Forced degradation studies were performed for famciclovir active substance, reconstituted matrix and 500 mg tablets using the parameters like acid, base, peroxide, temperature, light, and relative humidity. Peak purity index was checked using PDA detection to demonstrate the specificity and stability indicating nature of the method. The developed method was validated for precision, ruggedness, linearity, LOD, LOQ, range, robustness and accuracy. The developed method can be used for regular quality control and stability study applications of famciclovir bulk drug and tablet dosage forms.


Column liquid chromatography Stability indicating method Forced degradation Method validation Famciclovir and penciclovir 



The authors thank the management of the APL group for supporting and providing the samples for this work and their colleagues in APL R&D Analytical Research Division for their co-operation in carrying out this work.


  1. 1.
    Tyring S, Engst R, Corriveau C, Robilland N, Trottire S, Van Slycken S, Crann RA, Locke LA, Saltzman R, Palestine AG (2001) Br J Ophathamol 85:576–581CrossRefGoogle Scholar
  2. 2.
    Srinubabu G, Sudharani B, Sridhar L, Rao JVLNS (2006) Chem Pharm Bull 54:819–822CrossRefGoogle Scholar
  3. 3.
    Nizamuddin S, Gurupadayya BM, Ravi MC, Manohara YN, Raju SA (2007) Ind J Pharm Sci 69:451–453CrossRefGoogle Scholar
  4. 4.
    Gouda AA, Shafey ZE, Hossny N, El-Azzazy R (2008) Spectrochim Acta Part A 70:785–792CrossRefGoogle Scholar
  5. 5.
    Hsu LC, Comstable DJ, Orvos DR (2002) J Chromatogr B 772:291–297CrossRefGoogle Scholar
  6. 6.
    McMeekin JR, Fowles SE, Winton CF (1992) Anal Proc 29:178–180Google Scholar
  7. 7.
    Winton CF, Fowles SE, Pierce DM (1990) Anal Proc 27:181–182Google Scholar
  8. 8.
    Boike SC, Pue MA, Freed MI (1994) Clin Pharmacol Ther 55:418Google Scholar
  9. 9.
    ICH Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (Q7) (2000) International Conference on Harmonization, IFPMA, GenevaGoogle Scholar
  10. 10.
    ICH Stability Testing of New Drug Substances and Products (Q1AR2) (2003) International Conference on Harmonization, IFPMA, GenevaGoogle Scholar
  11. 11.
    ICH Draft Guidelines on Validation of Analytical Procedures (Q2R1) (1995) Text and methodology, IFPMA, SwitzerlandGoogle Scholar
  12. 12.
    Raju ChBVN, Sharma HK, Rao ChS, Rao GN (2008) Anal Chem Indian J (in press)Google Scholar

Copyright information

© Vieweg+Teubner | GWV Fachverlage GmbH 2008

Authors and Affiliations

  • Ch. B. V. Narasimha Raju
    • 1
  • Gunanidhi Panda
    • 1
  • G. Nageswara Rao
    • 2
  1. 1.Aurobindo Pharma LimitedPydibhimavaramIndia
  2. 2.Department of Inorganic and Analytical ChemistryAndhra UniversityVisakhapatnamIndia

Personalised recommendations